• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Mayo Clinic

Fine-tuning formulation with Fluid Imaging Technologies’ FlowCam

April 6, 2018 By Sarah Faulkner

Fluid Imaging Technologies FlowCam

After seven people died in 2013 from serious allergic reactions to Omontys, an injectable anemia drug marketed by Takeda Pharmaceutical (TYO:4502) and Affymax, the companies recalled the product and regulators launched an investigation to find out the cause of such an unexpected rate of anaphylaxis. Omontys was made and cleared in a single-use vial and a multi-use […]

Filed Under: Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Imaging, Pharmaceuticals, Regulatory/Compliance Tagged With: fluidimagingtechnologies, Mayo Clinic, Takeda Pharmaceutical Co

TapImmune brings therapeutic vaccines into the clinic for ovarian, breast cancer

January 23, 2018 By Sarah Faulkner

TapImmune

In the past decade, new innovations and well-funded research have heralded in the era of immunotherapy. The pace of change within the field has amazed Peter Hoang, the chief executive of a Jacksonville, Fl.-based company working to develop therapeutic vaccines for cancer. “15 years ago, if you or I walked into a venture capitalist’s office, […]

Filed Under: Clinical Trials, Featured, Immunotherapy, Oncology, Pharmaceuticals, Research & Development, Wall Street Beat Tagged With: AstraZeneca plc, Mayo Clinic, memorialsloankettering, tapimmune

ASTRO ’17 Round-up: Novocure touts five-year results for Optune, chemo combo in newly-diagnosed glioblastoma patients

September 25, 2017 By Sarah Faulkner

American Society for Radiation Oncology ASTRO annual meeting

Novocure (NSDQ:NVCR) touted data today from the Phase III pivotal trial of its Optune device in combination with temozolomide for the treatment of newly-diagnosed glioblastoma. The analyses were presented at the American Society for Radiation Oncology’s 2017 annual meeting in San Diego. The company’s EF-14 trial showed unprecedented five-year survival results in patients with newly-diagnosed GBM, […]

Pages: Page 1 Page 2 Page 3 Page 4 Page 5 Page 6

Filed Under: Clinical Trials, Drug-Device Combinations, Featured, Oncology, Pharmaceuticals, Wall Street Beat Tagged With: Mayo Clinic, NovoCure, Royal Philips, viewray

Study: Women with esophageal cancer fare better than men

September 19, 2017 By Sarah Faulkner

Hospital

The survival rate for esophageal cancer is, according to Dr. K. Robert Shen, bleak. Last year, there were 17,000 Americans diagnosed with the disease and nearly 16,000 of them died, the Mayo Clinic cardiothoracic surgeon told Drug Delivery Business News. “It’s almost reached an epidemic,” Shen said. “It doesn’t get a lot of airplay and […]

Filed Under: Featured, Oncology, Pharmaceuticals, Women's Health Tagged With: Mayo Clinic

Mayo Clinic, nference launch startup to leverage AI for drug development

July 14, 2017 By Sarah Faulkner

Mayo Clinic

Mayo Clinic and nference today launched a startup, Qrativ, focused on drug development driven by artificial intelligence. The company, backed by a $8.3 million Series A round, plans to combine nference’s AI platform and Mayo Clinic’s clinical data. Qrativ hopes to use AI to discover potential new therapeutic indications for drugs earlier in development, in […]

Filed Under: Discovery, Featured, Pharmaceuticals, Technology, Wall Street Beat Tagged With: Mayo Clinic, nference, qrativ

Study: Nanoparticle shrinks tumor size by 80% in mouse model

May 5, 2017 By Sarah Faulkner

Mayo Clinic

Researchers from the Mayo Clinic have developed a type of cancer-fighting nanoparticle that is designed to shrink breast cancer tumors and prevent recurrence. In a mouse model, the therapy yielded a 70-80% reduction in tumor size and mice treated with the nanoparticles demonstrated resistance to future tumor recurrence a month later. The nanoparticle is coated […]

Filed Under: Featured, Immunotherapy, Nanoparticles, Oncology, Preclinical Trials, Research & Development Tagged With: Mayo Clinic

Medtech stories we missed this week: April 21, 2017

April 21, 2017 By Danielle Kirsh

canyon at sunset

From new and renewed partnerships to FDA approvals, here are medtech stories we missed this week but thought were still worth mentioning. 1. Life Spine receives FDA clearance for cervical spacer system Life Spine announced in an April 19 press release that it has received FDA 510(k) clearance for its Plateau-C Ti Cervical Spacer System. The system uses […]

Filed Under: Featured, Food & Drug Administration (FDA), Regulatory/Compliance Tagged With: Clearflow, Condor, Getinge, Life Spine, Lifetrack, Mayo Clinic, Owlstone Medical, Physio-Control, Remedent

New blood-based test could detect all lung cancer types

March 7, 2017 By Danielle Kirsh

lungcancerMD

Exact Sciences and the Mayo Clinic recently collaborated on a blood-based lung cancer test that researchers say has shown high accuracy for detecting all stages of lung cancer. “These results reveal an opportunity to detect lung cancer from a simple blood draw,” said Kevin Conroy, chairman and CEO of Exact Sciences, in a news release. “Our […]

Filed Under: Featured, Oncology Tagged With: American Association for Cancer Research, Cancer, Exact Sciences, lung cancer, Mayo Clinic, medtech

Researchers develop 3D-printed, bioabsorbable scaffold for ACL reconstruction

February 27, 2017 By Sarah Faulkner

Researchers at the Mayo Clinic‘s tissue engineering and biomaterials laboratory have developed a 3D-printed, porous scaffold for the delayed delivery of recombinant-human bone morphogenetic protein 2, rhBMP-2, to facilitate bone regeneration in patients undergoing ACL reconstruction. The team’s work developing the scaffold and comparing different delivery methods for rhBMP-2 was published this week in Tissue Engineering.  […]

Filed Under: Featured, Orthopedics, Regenerative Medicine, Research & Development Tagged With: Mayo Clinic, Medtronic

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS